ISSN: 1859 - 2872
Research on the correlation between flow-mediated dilation (FMD) and several clinical and paraclinical characteristics in kidney transplant patients
Main Article Content
Keywords
Abstract
Objective: To determine the correlation between the flow-mediated dilation (FMD) index and several clinical and paraclinical characteristics in kidney transplant patients after 3 months. Subject and method: A cross-sectional descriptive study was conducted on 95 kidney transplant patients at Military Hospital 103 from June 2025 to June 2026. Result: The mean FMD index was 7.4 ± 1.76%. The group with a post-transplant duration of over 2 years had a significantly higher rate of FMD% ≥ 7.1% (71.6%) compared to the group with a duration of < 2 years (42.9%), p<0.05. The prevalence of endothelial dysfunction (FMD < 7.1%) reached 93.7% in the group with eGFR < 60mL/min/1.73m2, which was significantly higher than in the group with eGFR > 60 mL/min/1.73m2 (20.2%), p<0.001. Conclusion: The FMD% index in kidney transplant patients is closely correlated with the duration of the transplant and the function of the renal graft.
Article Details
References
2. Kundhal K and Lok CE (2005) Clinical epidemiology of cardiovascular disease in chronic kidney disease. Nephron Clin Pract 101 (2): 47-52.
3. Yasushi Matsuzawa, Taek‐Geun Kwon, Ryan J Lennon et al (2015) Prognostic value of flow‐mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: A systematic review and meta‐analysis. Journal of the American Heart Association 4 (11): e002270.
4 Zhe Wang, Wei Wang, Yihang Jiang. et al (2018) Assessment of endothelial and renal dysfunction in patients after renal transplantation.
5. Prabhahar A, Batta A, Hatwal J et al (2025) Endothelial dysfunction in the kidney transplant population: Current evidence and management strategies. World J Transplant 15 (1): 97458.
6. Lorenzo Ghiadoni, Daniele Versari, Chiara Giannarelli et al (2008) Non-invasive diagnostic tools for investigating endothelial dysfunction. Current pharmaceutical design 14 (35): 3715-3722.
7. Dick HJ Thijssen, Mark A Black, Kyra E Pyke et al (2011) Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. American Journal of Physiology-Heart Circulatory Physiology 300 (1): H2-H12.
8. Tatsuya Maruhashi, Masato Kajikawa, Shinji Kishimoto et al (2020) Diagnostic criteria of flow‐mediated vasodilation for normal endothelial function and nitroglycerin‐induced vasodilation for normal vascular smooth muscle function of the brachial artery. Journal of the American Heart Association 9(2): 013915.
9. Nina Elisabeth Langberg, Trond G Jenssen, Anders J Haugen et al (2022) Endothelial dysfunction and 6-year risk of mortality in kidney transplant recipients. Transplantation direct 8(1): 1262.
10 Huseyin Kocak, Kaan Ceken, Asuman Yavuz et al (2006) Effect of renal transplantation on endothelial function in haemodialysis patients. Nephrology Dialysis Transplantation 21 (1): 203-207.
11. Celermajer DS, Sorensen KE, Gooch VM et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet 340 (8828): 1111-1115.
12. Cho ME, Brunt VE, Shiu YT et al (2025) Endothelial dysfunction in chronic kidney disease: A clinical perspective. Am J Physiol Heart Circ Physiol 329 (1): H135-h153.
Article Sidebar
